Rare Bleeding Disorders in the Netherlands

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

November 7, 2017

Primary Completion Date

July 1, 2021

Study Completion Date

January 1, 2022

Conditions
Rare Bleeding Disorders
Interventions
GENETIC

WES

136 bleeding related OMIM (Online Mendelian Inheritance in Man)-proved genes involved in haemostasis will be selected from Whole Exome Sequencing (WES)

DIAGNOSTIC_TEST

Several assays

Patients will be approached by their own treating physician. Data will be collected through questionnaires, a clinical interview, a blood and saliva sample obtained from each participant, and thorough review of electronic patient records. All procedures are study related. In case a physician visit with the treating physician is already planned, or in case a venepuncture for regular diagnostics or treatment is already planned, this can be combined with the study procedures to prevent an extra visit.

Trial Locations (7)

Unknown

RECRUITING

Academisch Medisch Centrum, Amsterdam

RECRUITING

University Medical Center Groningen (UMCG), Groningen

6500 PD

RECRUITING

Maxima Medisch Centrum, Eindhoven

6202 AZ

RECRUITING

Maatricht UMC+, Maastricht

6525 GA

RECRUITING

Radboud university medical center, Nijmegen

3000CA

RECRUITING

Erasmus MC, Rotterdam

2545AA

RECRUITING

Haga hospital, The Hague

All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Academisch Ziekenhuis Maastricht

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Maxima Medical Center

OTHER

collaborator

Academisch Ziekenhuis Groningen

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Haga Hospital

OTHER

lead

Radboud University Medical Center

OTHER